ATP 2016

EORTC 22113-08113: LUNGTECH  VU monocenter experience: Data with risk-adapted doses show good local control rates and moderate toxicity [Haasbeek, J Thor Oncol 2009] :  SBRT: 60 Gy in 8 fractions of 7.5 Gy will be given alternate days, i.e. over a total treatment time of 2.5 weeks EORTC 22113-08113: LungTech Stereotactic Body Radiotherapy (SBRT) of medically inoperable patients with centrally located NSCLC Study Coordinator: Ursula Nestle

A study of the EORTC Radiation Oncology and Lung Cancer Groups

German Cancer Consortium (DKTK)